Bacterial Infections
📧 Sign up to get email alerts when something new happens for Bacterial Infections.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-07-21Clinical Trial Update: Optimizing Sysmex Technology as an Innovative Tool to Differentiate Between Malaria (PALUdism) and BACterial Infections in a Malaria Endemic Region
This completed clinical trial assessed using Sysmex technology to differentiate malaria from bacterial infections in a malaria-endemic regio…
-
CLINICAL_TRIALS trial_result · 2017-07-13Clinical Trial Update: Relative Bioavailability, Safety, Tolerability, Pharmacokinetics (PK) and Food Effect Study of GSK2140944 in Healthy Subjects [Phase 1]
Phase 1 study in healthy subjects assessing relative bioavailability, safety, tolerability, pharmacokinetics, and the effect of food on GSK2…
-
CLINICAL_TRIALS trial_result · 2017-06-26Clinical Trial Update: Relative Bioavailability Study in Healthy Subjects [Phase 1]
This release documents a Phase 1 relative bioavailability study in healthy subjects for a GlaxoSmithKline compound being developed for bacte…
-
CLINICAL_TRIALS trial_result · 2017-06-20Clinical Trial Update: Single Dose Escalation First Time in Human PK Study [Phase 1]
GlaxoSmithKline reports completion of a first-in-human, single-dose escalation PK study in Phase 1.
-
CLINICAL_TRIALS trial_result · 2017-06-12Clinical Trial Update: A Study to Investigate the Recovery, Excretion, and Pharmacokinetics of 14C -GSK1322322 After an Intravenous and an Oral Dose [Phase 1]
A Phase 1 study completed to assess recovery, excretion, and pharmacokinetics of radiolabeled GSK1322322 after intravenous and oral dosing i…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-06-09Clinical Trial Update: Pharmacokinetics and Safety of Solithromycin in Adolescents and Children [Phase 1]
Phase 1 pharmacokinetics and safety data for solithromycin in adolescents and children were reported from a completed study.
-
CLINICAL_TRIALS trial_result · 2017-05-18Clinical Trial Update: The INFECIR-2 Albumin Prevention Study [Phase 4]
The INFECIR-2 Albumin Prevention Study is a Phase 4 trial sponsored by the EASL-CLIF Consortium. It has been terminated; no results are prov…
-
CLINICAL_TRIALS trial_result · 2017-05-15Clinical Trial Update: To Evaluate Plasma and Pulmonary Pharmacokinetics of GSK2140944 [Phase 1]
Phase 1 study evaluating the plasma and pulmonary pharmacokinetics of GSK2140944 in bacterial infections; the trial has completed.
-
CLINICAL_TRIALS trial_result · 2017-05-03Clinical Trial Update: Infant Antibiotic Resistance and Implications for Therapeutic Decision-making
This completed clinical trial update discusses infant antibiotic resistance and its implications for how therapies are chosen for these pati…
-
CLINICAL_TRIALS research · 2017-03-22Clinical Trial Update: A Study to Assess the Relative Bioavailability of Three Formulations and Food Effect on GSK1322322 in Healthy Subjects [Phase 1]
Phase 1 clinical trial update assessing the relative bioavailability of three formulations of GSK1322322 and the effect of food in healthy s…
-
CLINICAL_TRIALS trial_result · 2017-01-16Clinical Trial Update: Use of Mobile Phones for Thermal Imaging of the Chest to Save Lives of Children With Pneumonia in Nagpur, India [NA]
A completed trial evaluating the use of mobile phone thermal imaging of the chest to aid diagnosis and management of bacterial pneumonia in …
-
CLINICAL_TRIALS trial_result · 2017-01-12Clinical Trial Update: Trial of Rapid Diagnostic Tests in Rural Ghana [Phase 4]
A Phase 4 trial update from the London School of Hygiene and Tropical Medicine reports completion of a study evaluating rapid diagnostic tes…
-
EMA withdrawal · 2016-12-06EMA Application withdrawn: Ertapenem Hospira (ertapenem sodium) — Hospira UK Limited
EMA has withdrawn the application for Ertapenem Hospira (ertapenem sodium) by Hospira UK Limited.
-
CLINICAL_TRIALS trial_result · 2016-11-15Clinical Trial Update: MALDITOF Versus Routine Clinical Microbiology for Identifying Pathogens; a Randomized Diagnostic Trial [NA]
A randomized diagnostic trial comparing MALDI-TOF mass spectrometry to routine clinical microbiology for identifying bacterial and fungal pa…
-
CLINICAL_TRIALS trial_result · 2016-10-26Clinical Trial Update: To Investigate the Safety and Tolerability of Aztreonam-Avibactam (ATM-AVI) [Phase 1]
Phase 1 safety and tolerability trial of aztreonam-avibactam (ATM-AVI) in complicated infections has completed with results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-10-19Clinical Trial Update: Safety and Pharmacokinetics of Clindamycin in Pediatric Subjects With BMI ≥ 85th Percentile [Phase 1]
This Phase 1 trial update reports safety and pharmacokinetics data for clindamycin in pediatric subjects with BMI at or above the 85th perce…
-
CLINICAL_TRIALS trial_result · 2016-10-13Clinical Trial Update: Local Collagen-Gentamicin and Extra Fixation of the Sternum for Prevention of Sternal Wound Infection in Cardiac Surgery [NA]
This completed clinical trial evaluated using a collagen-Gentamicin local application with extra sternum fixation to prevent sternal wound i…
-
CLINICAL_TRIALS research · 2016-07-19Clinical Trial Update: Preauthorization Versus Prospective Audit in Antimicrobial Stewardship Program [NA]
The document provides an update on a clinical trial comparing preauthorization versus prospective audit in an antimicrobial stewardship prog…
-
CLINICAL_TRIALS trial_result · 2016-06-17Clinical Trial Update: Early Procalcitonin Kinetics During Empirical Antibiotic Therapy in Critically Ill Patients
This ClinicalTrials.gov entry reports on a completed study evaluating procalcitonin kinetics during empirical antibiotic therapy in critical…
-
CLINICAL_TRIALS trial_result · 2016-05-19Clinical Trial Update: Ascending Dose Pharmacokinetic (PK) and Absolute Bioavailability (BA) [Phase 1]
Phase 1 study reports ascending-dose pharmacokinetics and absolute bioavailability for an antibiotic developed by Trius Therapeutics (a Merc…
-
FDA approval · 2016-05-12FDA Approved: CLINDAMYCIN PHOSPHATE — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)
FDA approved the supplemental application for clindamycin phosphate (Padagis Israel Pharmaceuticals Ltd), reflecting approval of the supplem…
-
CLINICAL_TRIALS trial_result · 2016-05-02Clinical Trial Update: A Study of V419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-006) [Phase 3]
Phase 3 clinical trial update for V419 given with Prevnar 13 and RotaTeq; study completed with results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-03-16Clinical Trial Update: Safety, Tolerability, and Immunogenicity of V419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-005) [Phase 3]
Phase 3 clinical trial update on V419 given with Prevnar 13 and RotaTeq, focusing on safety, tolerability, and immunogenicity; study complet…
-
CLINICAL_TRIALS trial_result · 2016-03-07Clinical Trial Update: Safety & Efficacy of an Antibacterial Protein Molecule Applied Topically to the Nostrils of Volunteers and Patients [Phase 1, Phase 2]
Phase 1/Phase 2 trials evaluating the safety and preliminary efficacy of a topical antibacterial protein molecule applied to the nostrils in…
-
FDA approval · 2016-01-21FDA Approved: CLEOCIN HYDROCHLORIDE — Supplemental Application (Pharmacia & Upjohn Company LLC)
The FDA approved a supplemental application for CLEOCIN HYDROCHLORIDE (clindamycin hydrochloride) filed by Pharmacia & Upjohn Company LLC.